We are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Reset all filters
01 20Alfred E Tiefenbacher GmbH
02 5Pharmathen SA
03 92care4
04 6Abiogen Pharma Spa
05 7Actavis Inc
06 5Adcock Ingram
07 3Alkem Laboratories
08 9Collegium Pharmaceutical
09 8Endo International
10 1G.L. Pharma GmbH
11 7G.L. Pharma Gmbh
12 5GL Pharma
13 73Grunenthal
14 2Health Biotech
15 2Hubei Gedian Humanwell Pharmaceutical
16 3Krka
17 3MEDOCHEMIE LTD
18 16Medical Valley
19 3Novagen Healthcare
20 4ORIFARM GROUP AS
21 9Orchid Pharma
22 7Precise Group
23 2RHODES PHARMACEUTICALS LP
24 3ROXANE
25 5Sandoz B2B
26 5Seqirus
27 1Vega Biotech Pvt. Ltd.
28 4West-ward Pharmaceutical Corp
29 12Blank
Reset all filters
01 7ER TABLET
02 4ER Tablet
03 10Extended Release Tablets
04 15Extended-Release Tablet
05 25Film Coated Tablet
06 8Oral Solution
07 5Prolonged Release Tablet
08 2SOLUTION;ORAL
09 12SR Tablet
10 3SRT
11 4Solution
12 2Syrup
13 2TAB
14 3TABLET
15 5TABLET (EXTENDED-RELEASE)
16 3TABLET (IMMEDIATE RELEASE)
17 14TABLET, EXTENDED RELEASE;ORAL
18 2TABLET; ORAL
19 12TABLET;ORAL
20 80Tablet
21 1Tapentadolo 100Mg 30 Joined' Oral Use Rp
22 1Tapentadolo 150Mg 30 Joined' Oral Use Rp
23 1Tapentadolo 200Mg 30 Joined' Oral Use Rp
24 1Tapentadolo 250Mg 30 Joined' Oral Use Rp
25 1Tapentadolo 25Mg 40 Combined Oral Use Rp
26 1Tapentadolo 50Mg 30 Joined' Oral Use Rp
27 10XR Tablet
28 5Blank
Reset all filters
01 26Approved
02 23Authorized
03 2Cancelled
04 1DISCN
05 34Deregistered
06 2EU Dossier Readiness-Q1 2020
07 4EU Dossier Readiness-Q3 2019
08 8Generic
09 9Generic EU CTD
10 28Marketed
11 8NARCOTICS (CDSA I)
12 5Originator
13 3Prescription
14 8RX
15 14Status- Early Development
16 12Under registration in India
17 52Blank
Reset all filters
01 3Ationdo
02 6Ationdo Depot
03 4NUCYNTA
04 5NUCYNTA ER
05 5NUCYNTA EXTENDED-RELEASE
06 3NUCYNTA IR
07 20Palexia
08 1Palexia 100 mg
09 1Palexia 50 mg
10 15Palexia Depot
11 6Palexia Retard
12 5Palexia SR
13 1Palexia SR 100 mg
14 1Palexia SR 200 mg
15 1Palexia SR 50 mg
16 14Palexia depot
17 5TADOMON
18 5TAPELOD
19 16TAPENTADOL
20 5TAPENTADOL HYDROCHLORIDE
21 3Tapemed Retard
22 1Tapencet ER
23 6Tapentadol Depot Abiogen
24 6Tapentadol Depot G.L. Pharma
25 6Tapentadol Depot Medical Valley
26 1Tapentadol G.L. Pharma
27 1Tapentadol Gl Pharma
28 3Tapentadol Krka
29 10Tapentadol Medical Valley
30 10Yantil
31 6Yantil Depot
32 6Yantil Retard
33 58Blank
Reset all filters
01 5Australia
02 8Canada
03 3Estonia
04 20Germany
05 5Greece
06 34India
07 16Italy
08 28Norway
09 5South Africa
10 25Spain
11 60Sweden
12 30USA
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany